{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:38:04Z","timestamp":1791081484440,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A15"],"award-info":[{"award-number":["A15"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 704"],"award-info":[{"award-number":["SFB 704"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.2353\/ajpath.2007.070281","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T20:34:26Z","timestamp":1196454866000},"page":"1936-1943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Indoleamine 2,3-Dioxygenase (IDO)"],"prefix":"10.1016","volume":"171","author":[{"given":"Marina","family":"Scheler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"von Bubnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2007.070281_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1042819031000149368","article-title":"Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation","volume":"45","author":"Tough","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.2353\/ajpath.2007.070281_bib2","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1073\/pnas.0403555101","article-title":"Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways","volume":"101","author":"Hochrein","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.070281_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0952-7915(00)00111-4","article-title":"The function of type I interferons in antimicrobial immunity","volume":"12","author":"Bogdan","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/path.1699","article-title":"Recruitment of dendritic cells in oral lichen planus","volume":"205","author":"Santoro","year":"2005","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2007.070281_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon-alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2007.070281_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08916930310001602128","article-title":"Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity","volume":"36","author":"R\u00f6nnblom","year":"2003","journal-title":"Autoimmunity"},{"key":"10.2353\/ajpath.2007.070281_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2007.070281_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.2353\/ajpath.2007.070281_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2007.070281_bib10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.2353\/ajpath.2007.070281_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.2353\/ajpath.2007.070281_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-2133.2005.06784.x","article-title":"Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.2353\/ajpath.2007.070281_bib13","unstructured":"Wenzel J, Peters B, Zahn S, Birth M, Hofmann K, Kusters D, Tomiuk S, Baron JM, Merk HF, Mauch C, Krieg T, Bieber T, Tuting T, Bosio A: Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol [Epub ahead of print]"},{"key":"10.2353\/ajpath.2007.070281_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2005.08.232","article-title":"Indoleamine 2,3 dioxygenase and regulation of T cell immunity","volume":"338","author":"Mellor","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.2353\/ajpath.2007.070281_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/eji.200535602","article-title":"Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO","volume":"36","author":"Wingender","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2007.070281_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1472-8206.2006.00460.x","article-title":"Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages","volume":"21","author":"Maneglier","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.2353\/ajpath.2007.070281_bib18","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.4049\/jimmunol.147.8.2617","article-title":"A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma","volume":"147","author":"Recht","year":"1991","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1471-4906(03)00072-3","article-title":"Tolerance. DCs and tryptophan: much ado about IDO","volume":"24","author":"Grohmann","year":"2003","journal-title":"Trends Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib20","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3254::AID-IMMU3254>3.0.CO;2-0","article-title":"Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis","volume":"29","author":"MacKenzie","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2007.070281_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI21275","article-title":"Inhibition of experimental asthma by indoleamine 2,3-dioxygenase","volume":"114","author":"Hayashi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2007.070281_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","article-title":"A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation","volume":"106","author":"Braun","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.070281_bib24","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02125.x","article-title":"Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE. Fc(epsilon)RI and interferon-gamma stimulation","volume":"132","author":"von Bubnoff","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1034\/j.1600-0854.2002.31003.x","article-title":"Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity","volume":"3","author":"Haller","year":"2002","journal-title":"Traffic"},{"key":"10.2353\/ajpath.2007.070281_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0303-6987.2005.00297.x","article-title":"Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod","volume":"32","author":"Wenzel","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.2353\/ajpath.2007.070281_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.0022-202X.2004.23217.x","article-title":"Human epidermal Langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase","volume":"123","author":"von Bubnoff","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.2353\/ajpath.2007.070281_bib29","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells inuced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.070281_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0091-6749(03)02014-1","article-title":"Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle?","volume":"112","author":"von Bubnoff","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.2353\/ajpath.2007.070281_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/43.1.7822763","article-title":"Expression of MxA protein in inflammatory dermatoses","volume":"43","author":"F\u00e4h","year":"1995","journal-title":"J Histochem Cytochem"},{"key":"10.2353\/ajpath.2007.070281_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/molehr\/8.4.385","article-title":"Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta","volume":"8","author":"Sedlmayr","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.2353\/ajpath.2007.070281_bib34","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1074\/jbc.M111906200","article-title":"Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma-induced CD40 expression in microglia\/macrophages","volume":"277","author":"Nguyen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.070281_bib35","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.4049\/jimmunol.161.12.6567","article-title":"The role of Stat4 in species-specific regulation of Th cell development by type I IFNs","volume":"161","author":"Rogge","year":"1998","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/eji.200737184","article-title":"On watching the watchers: IDO and type I\/II IFN","volume":"37","author":"Puccetti","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib37","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/eji.200636690","article-title":"Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells","volume":"37","author":"Manlapat","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.20030633","article-title":"A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice","volume":"198","author":"Grohmann","year":"2003","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2007.070281_bib39","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2222.2004.01984.x","article-title":"Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure","volume":"34","author":"von Bubnoff","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.2353\/ajpath.2007.070281_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/138920007780362608","article-title":"Indoleamine-2,3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection","volume":"8","author":"Schroecksnadel","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.2353\/ajpath.2007.070281_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1462-5822.2006.00716.x","article-title":"Interferon signalling network in innate defence","volume":"8","author":"Takaoka","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.2353\/ajpath.2007.070281_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0171-2985(00)80079-0","article-title":"Enhanced tryptophan degradation in systemic lupus erythematosus","volume":"201","author":"Widner","year":"2000","journal-title":"Immunobiology"},{"key":"10.2353\/ajpath.2007.070281_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm1563","article-title":"Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy","volume":"13","author":"Grohmann","year":"2007","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2007.070281_bib44","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2007.070281_bib45","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.4049\/jimmunol.173.6.3748","article-title":"Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement","volume":"173","author":"Fallarino","year":"2004","journal-title":"J Immunol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010624546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010624546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:16:23Z","timestamp":1757600183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010624546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0002944010624546"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2007.070281","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indoleamine 2,3-Dioxygenase (IDO)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2007.070281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}